Kamm, Christian Philipp http://orcid.org/0000-0002-3906-0161
Barin, L.
Gobbi, C.
Pot, C.
Calabrese, P.
Salmen, A.
Achtnichts, L.
Kesselring, J.
Puhan, M. A.
von Wyl, V.
Anderseck, Bernd
Calabrese, Pasquale
Chan, Andrew
Disanto, Giulio
Engelhardt, Britta
Gobbi, Claudio
Haussler, Roger
Kamm, Christian P.
Kagi, Susanne
Kesselring, Jurg
Kuhle, Jens
Kurmann, Roland
Lotter, Christoph
Luyckx, Kurt
Merkler, Doron
Monin, Patricia
Muller, Stephanie
Nedeltchev, Krassen
Pot, Caroline
Puhan, Milo A.
Rapold, Irene
Salmen, Anke
Schippling, Sven
Vaney, Claude
von Wyl, Viktor
,
Funding for this research was provided by:
Schweizerische Multiple Sklerose Gesellschaft
Article History
Received: 13 August 2019
Revised: 26 September 2019
Accepted: 28 September 2019
First Online: 8 October 2019
Compliance with ethical standards
:
: CPK has received honoraria for lectures as well as research support from Biogen, Novartis, Almirall, Bayer Schweiz AG, Teva, Merck, Sanofi Genzyme, Roche, Celgene and the Swiss MS Society (SMSG). CG: The Employer Department of Neurology, Regional Hospital Lugano (EOC), Lugano, Switzerland receives financial support from Teva, Merck Serono, Biogen Idec, Bayer Schering, Genzyme, Roche and Novartis. The submitted work is not related to these agreements. CP has received travel support and participated to advisory board for Biogen Idec, Genzyme, Novartis and Roche. PC has received honoraria for speaking at scientific meetings, serving at scientific advisory boards and consulting activities from: Abbvie, Actelion, Almirall, Bayer-Schering, Biogen Idec, EISAI, Genzyme, Lundbeck, Merck Serono, Novartis, Pfizer, Teva, and Sanofi-Aventis; his research is also supported by the Swiss Multiple Sclerosis Society, the Swiss National Research Foundation and the SOFIA Foundation. AS received speaker honoraria and/or travel compensation for activities with Almirall Hermal GmbH, Biogen, Merck, Novartis, Roche, and Sanofi Genzyme; none related to this work. LA served on scientific advisory boards for Novartis Pharmaceuticals, Merck, Biogen, Sanofi Genzyme, Roche and Bayer; received funding for travel and/or speaker honoraria from Biogen, Sanofi Genzyme, Novartis, Merck Serono, Roche, Teva and the Swiss MS Society. LB, MP, JK, and VvW have nothing to disclose.
: The SMSR was approved by the Cantonal Ethics Committee Zurich (Study number PB-2016-00894) and has been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments, and every patient has signed an informed consent prior to study entry.